IssuerAnnouncementDetailsV2Portlet
Saudi Chemical Company Holding Announces Signing MOU by Its Subsidiary AJA Pharma with Lagap SA
Element List | Explanation |
---|---|
Introduction | Saudi Chemical Company Holding (SCCH), through its pharmaceutical sector represented by AJA Pharmaceutical Industries Ltd. (AJA Pharma), announced signing MOU with Lagap SA, a Swiss-based Pharmaceuticals Company, to co-development pharmaceutical products and launch in the markets of Europe and the Middle East, in the Saudi Export stand during Arab Health Exhibition 2023 |
Memorandum Signing Date | 2023-02-01 Corresponding to 1444-07-10 |
Counterparty | Lagap SA, a Swiss-based Pharmaceuticals Company |
Memorandum Subject | The MOU with Lagap will focus on co-developing pharmaceutical products and launching in the markets of Europe and the Middle East. AJA Pharma and Lagap will explore the best utilization of their areas of strength in their respective markets and leverage their development, manufacturing, and resource capabilities for launching new products in the field of branded generics pharmaceuticals for the benefit of the patients and to contribute towards the objective of providing medicine security in the country and region. |
Memorandum Duration | One year |
Related Parties | None |
Financial Impact | The financial impact of this MOU will be determined later. |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.